These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 3805107)

  • 21. Low-dose heparin in gynecologic surgery: effect on blood coagulation tests.
    Levesque G; Samama M; Kher A; Barbier P; Horellou MH; Conard J
    Haemostasis; 1981; 10(2):97-103. PubMed ID: 7461507
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activated coagulation time test: a convenient monitor of heparinization for dogs used in cardiovascular research.
    Wilkerson RD; Conran PB; Greene SL
    Lab Anim Sci; 1984 Feb; 34(1):62-5. PubMed ID: 6716959
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activated partial thromboplastin time is a better trending tool in pediatric extracorporeal membrane oxygenation.
    Maul TM; Wolff EL; Kuch BA; Rosendorff A; Morell VO; Wearden PD
    Pediatr Crit Care Med; 2012 Nov; 13(6):e363-71. PubMed ID: 22940857
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo and in vitro evaluation of the heparin management test versus the activated coagulation time for monitoring anticoagulation level in aprotinin-treated patients during cardiac surgery.
    Kim YS; Murkin JM; Adams SJ
    Heart Surg Forum; 2004; 7(6):E599-604. PubMed ID: 15769695
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The monitoring of heparin administration by screening tests in experimental dogs.
    Mischke R; Jacobs C
    Res Vet Sci; 2001 Apr; 70(2):101-8. PubMed ID: 11356088
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemorheological studies of the effect of heparin on the course of coagulation.
    Overholser KA; Baysinger CB; Harris TR; Deveau T
    Thromb Haemost; 1976 Apr; 35(2):447-59. PubMed ID: 989642
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The monitoring of heparin activity during extracorporeal circulation.
    Gomperts ED; Bethlehem B; Hockley J
    S Afr Med J; 1977 Jun; 51(26):973-6. PubMed ID: 888033
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of activated recalcification and partial thromboplastin tests as controls of heparin therapy.
    Ray PK; Harper TA
    J Lab Clin Med; 1971 Jun; 77(6):901-7. PubMed ID: 5559859
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical evaluation of a new one-stage clotting assay for heparin and low molecular weight heparins.
    Harenberg J
    J Mal Vasc; 1987; 12 Suppl B():68-70. PubMed ID: 2834495
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heparin and partial thromboplastin time: an international survey.
    Poller L; Thomson JM; Yee KF
    Br J Haematol; 1980 Jan; 44(1):161-5. PubMed ID: 7378288
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peroperative effects of fresh frozen plasma and antithrombin III on heparin sensitivity and coagulation during nitroglycerine infusion in coronary artery bypass surgery.
    Kanbak M; Oc B; Salman MA; Ocal T; Oc M
    Blood Coagul Fibrinolysis; 2011 Oct; 22(7):593-9. PubMed ID: 21799398
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Validation of a bedside activated clotting time test (Hemochron Jr II Signature) with low dose heparin therapy.
    Racioppi L; Quinart A; Biais M; Nouette-Gaulain K; Revel P; Sztark F
    Anaesthesia; 2009 Apr; 64(4):430-4. PubMed ID: 19317710
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Laboratory observations and clinical implications of monitoring the effect of heparin by bioassay.
    Goodman TL; Todd ME; Goldsmith EI
    Surg Gynecol Obstet; 1976 May; 142(5):673-85. PubMed ID: 1265607
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monitoring heparin therapy with the activated partial thromboplastin time.
    Stuart RK; Michel A
    Can Med Assoc J; 1971 Mar; 104(5):385-8. PubMed ID: 5557913
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intraoperative autotransfusion in major elective vascular operations: a clinical assessment.
    Wall W; Heimbecker RO; McKenzie FN; Robert A; Barr R
    Surgery; 1976 Jan; 79(1):82-8. PubMed ID: 1246693
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Individual dosage schedule of heparin therapy in chronic hemodialysis by analytic studies of blood coagulation].
    Gläser V; Anstadt M
    Z Urol Nephrol; 1990 Mar; 83(3):133-40. PubMed ID: 2356667
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of heparin in nonionic contrast media on blood coagulation and its dose response curve.
    Hwang MH; Piao ZE; Sheu SH
    Cathet Cardiovasc Diagn; 1990 Dec; 21(4):275-7. PubMed ID: 2276203
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biological activity and safety of the subcutaneous administration of high doses of low molecular weight heparin for 8 days in human volunteers.
    Harenberg J; Giese C; Dempfle CE; Stehle G; Heene DL
    Thromb Haemost; 1989 Jun; 61(3):357-62. PubMed ID: 2552604
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heparin management during cardiac surgery with respect to various blood-conservation techniques.
    Boldt J; Zickmann B; Herold C; Scholz S; Dapper F; Hempelmann G
    Surgery; 1992 Mar; 111(3):260-5. PubMed ID: 1542853
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of heparin on three whole blood activated clotting tests and thrombin time.
    Uden DL; Seay RE; Kriesmer PJ; Cipolle RJ; Payne NR
    ASAIO Trans; 1991; 37(2):88-91. PubMed ID: 1854557
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.